136 related articles for article (PubMed ID: 22469703)
1. Isoquinoline derivatives as potent CRTH2 receptor antagonists: synthesis and SAR.
Nishikawa-Shimono R; Sekiguchi Y; Koami T; Kawamura M; Wakasugi D; Watanabe K; Wakahara S; Matsumoto K; Takayama T
Bioorg Med Chem Lett; 2012 May; 22(9):3305-10. PubMed ID: 22469703
[TBL] [Abstract][Full Text] [Related]
2. Isoquinoline derivatives as potent CRTH2 antagonists: design, synthesis and SAR.
Nishikawa-Shimono R; Sekiguchi Y; Koami T; Kawamura M; Wakasugi D; Watanabe K; Wakahara S; Kimura K; Yamanobe S; Takayama T
Bioorg Med Chem; 2013 Dec; 21(24):7674-85. PubMed ID: 24216094
[TBL] [Abstract][Full Text] [Related]
3. Isoquinoline derivatives as potent, selective, and orally active CRTH2 antagonists.
Nishikawa-Shimono R; Sekiguchi Y; Kawamura M; Wakasugi D; Kawanishi M; Watanabe K; Asakura Y; Takaoka A; Takayama T
Chem Pharm Bull (Tokyo); 2014; 62(6):528-37. PubMed ID: 24881658
[TBL] [Abstract][Full Text] [Related]
4. The synthesis of 2,3,6-trisubstituted 1-oxo-1,2-dihydroisoquinolines as potent CRTh
Huang X; Rao A; Zhou W; Aslanian R; Nargund R; Buevich A; Zhang LK; Qiu H; Yang X; Garlisi CG; Correll C; Palani A
Bioorg Med Chem Lett; 2017 Dec; 27(23):5344-5348. PubMed ID: 29110986
[TBL] [Abstract][Full Text] [Related]
5. Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold.
Beaulieu C; Guay D; Wang Z; Leblanc Y; Roy P; Dufresne C; Zamboni R; Berthelette C; Day S; Tsou N; Denis D; Greig G; Mathieu MC; O'Neill G
Bioorg Med Chem Lett; 2008 Apr; 18(8):2696-700. PubMed ID: 18359630
[TBL] [Abstract][Full Text] [Related]
6. Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids.
Luker T; Bonnert R; Schmidt J; Sargent C; Paine SW; Thom S; Pairaudeau G; Patel A; Mohammed R; Akam E; Dougall I; Davis AM; Abbott P; Brough S; Millichip I; McInally T
Bioorg Med Chem Lett; 2011 Jun; 21(12):3616-21. PubMed ID: 21592791
[TBL] [Abstract][Full Text] [Related]
7. Potent and highly selective DP1 antagonists with 2,3,4,9-tetrahydro-1H-carbazole as pharmacophore.
Li L; Beaulieu C; Carriere MC; Denis D; Greig G; Guay D; O'Neill G; Zamboni R; Wang Z
Bioorg Med Chem Lett; 2010 Dec; 20(24):7462-5. PubMed ID: 21036609
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of the 4-aminotetrahydroquinoline derivatives, selective chemoattractant receptor-homologous molecule expressed on T helper 2 cell antagonists, on eosinophil migration induced by prostaglandin D2.
Mimura H; Ikemura T; Kotera O; Sawada M; Tashiro S; Fuse E; Ueno K; Manabe H; Ohshima E; Karasawa A; Miyaji H
J Pharmacol Exp Ther; 2005 Jul; 314(1):244-51. PubMed ID: 15798001
[TBL] [Abstract][Full Text] [Related]
9. On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2.
Mathiesen JM; Christopoulos A; Ulven T; Royer JF; Campillo M; Heinemann A; Pardo L; Kostenis E
Mol Pharmacol; 2006 Apr; 69(4):1441-53. PubMed ID: 16418339
[TBL] [Abstract][Full Text] [Related]
10. 3-Indolyl sultams as selective CRTh2 antagonists.
Tumey LN; Robarge MJ; Gleason E; Song J; Murphy SM; Ekema G; Doucette C; Hanniford D; Palmer M; Pawlowski G; Danzig J; Loftus M; Hunady K; Sherf B; Mays RW; Stricker-Krongrad A; Brunden KR; Bennani YL; Harrington JJ
Bioorg Med Chem Lett; 2010 Jun; 20(11):3287-90. PubMed ID: 20457519
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent CRTh2 (DP2) receptor antagonists.
Birkinshaw TN; Teague SJ; Beech C; Bonnert RV; Hill S; Patel A; Reakes S; Sanganee H; Dougall IG; Phillips TT; Salter S; Schmidt J; Arrowsmith EC; Carrillo JJ; Bell FM; Paine SW; Weaver R
Bioorg Med Chem Lett; 2006 Aug; 16(16):4287-90. PubMed ID: 16753296
[TBL] [Abstract][Full Text] [Related]
12. 2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists.
Andrés M; Bravo M; Buil MA; Calbet M; Castillo M; Castro J; Eichhorn P; Ferrer M; Lehner MD; Moreno I; Roberts RS; Sevilla S
Eur J Med Chem; 2014 Jan; 71():168-84. PubMed ID: 24292338
[TBL] [Abstract][Full Text] [Related]
13. Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Crosignani S; Prêtre A; Jorand-Lebrun C; Fraboulet G; Seenisamy J; Augustine JK; Missotten M; Humbert Y; Cleva C; Abla N; Daff H; Schott O; Schneider M; Burgat-Charvillon F; Rivron D; Hamernig I; Arrighi JF; Gaudet M; Zimmerli SC; Juillard P; Johnson Z
J Med Chem; 2011 Oct; 54(20):7299-317. PubMed ID: 21916510
[TBL] [Abstract][Full Text] [Related]
14. Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 1.
Rist Ø; Grimstrup M; Receveur JM; Frimurer TM; Ulven T; Kostenis E; Högberg T
Bioorg Med Chem Lett; 2010 Feb; 20(3):1177-80. PubMed ID: 20031403
[TBL] [Abstract][Full Text] [Related]
15. Optimization of phenylacetic acid derivatives for balanced CRTH2 and DP dual antagonists.
Liu JJ; Wang Y; Johnson MG; Li AR; Shen W; Wang X; Su Y; Brown M; Van Lengerich B; Rickel E; Martin T; Budelsky A; Seitz L; Danao J; Tang HL; Collins T; Medina JC
Bioorg Med Chem Lett; 2012 Feb; 22(4):1686-9. PubMed ID: 22264478
[TBL] [Abstract][Full Text] [Related]
16. Azaindoles as potent CRTH2 receptor antagonists.
Simard D; Leblanc Y; Berthelette C; Zaghdane MH; Molinaro C; Wang Z; Gallant M; Lau S; Thao T; Hamel M; Stocco R; Sawyer N; Sillaots S; Gervais F; Houle R; Lévesque JF
Bioorg Med Chem Lett; 2011 Jan; 21(2):841-5. PubMed ID: 21185722
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Crosignani S; Page P; Missotten M; Colovray V; Cleva C; Arrighi JF; Atherall J; Macritchie J; Martin T; Humbert Y; Gaudet M; Pupowicz D; Maio M; Pittet PA; Golzio L; Giachetti C; Rocha C; Bernardinelli G; Filinchuk Y; Scheer A; Schwarz MK; Chollet A
J Med Chem; 2008 Apr; 51(7):2227-43. PubMed ID: 18318469
[TBL] [Abstract][Full Text] [Related]
18. 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.
Sandham DA; Adcock C; Bala K; Barker L; Brown Z; Dubois G; Budd D; Cox B; Fairhurst RA; Furegati M; Leblanc C; Manini J; Profit R; Reilly J; Stringer R; Schmidt A; Turner KL; Watson SJ; Willis J; Williams G; Wilson C
Bioorg Med Chem Lett; 2009 Aug; 19(16):4794-8. PubMed ID: 19592244
[TBL] [Abstract][Full Text] [Related]
19. Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffold.
Valdenaire A; Pothier J; Renneberg D; Riederer MA; Peter O; Leroy X; Gnerre C; Fretz H
Bioorg Med Chem Lett; 2013 Feb; 23(4):944-8. PubMed ID: 23324405
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel and potent CRTH2 antagonists.
Ito S; Terasaka T; Zenkoh T; Matsuda H; Hayashida H; Nagata H; Imamura Y; Kobayashi M; Takeuchi M; Ohta M
Bioorg Med Chem Lett; 2012 Jan; 22(2):1194-7. PubMed ID: 22178554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
